Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
7.9 Million shares purchased at .0017 in 4 minutes. The cherry on top is a 150k buy for the .0018 close. It looks like our prophets of the triple zeros won't be showing up any longer.
Over 4 mil purchased at .0016 . Is TAZZER buying again?
Hello simpsonly. One has to do a lot of speculation when trying to account for the actions of the FDA. When the FDA proposed that the FDA relax the controls on SWD it looked like a done deal. Now we sit some 60 days past the FDA time line with no closure. You mentioned changes to the proposed order and that has been my hope also, well as long as they go further than the proposed order in reducing regulations.
I can't recall specifics but wasn't there talk of a new Medical Device Division department head in late summer? If correct this could have slowed up the pipeline.
Have a safe trip and once again thanks for sharing your knowledge with the board.
Looking good today as several .0016 buys and a brief sighting of .0017.
TJ, I keep wanting to use the term "Wonder Drug". But that is one of the best things about the ActiPatch, it is not a drug, not addictive, not going to cook your kidneys or liver. So I guess "Wonder Device". It seems criminal that the power of PEMF, which Tesla experimented with 100 years ago has been resigned to a fringe use for a handful of ailments. If we can ever get on a level playing field with Tylenol and Advil I feel most people will go for the patch.
Art, First hand experience is what sold me on BIEL. I don't like to fly and anything over 3 hours in a car was agony from back pain. Actipatch changed all of that. This summer I did 17 hours of driving in one day on a trip to Seattle. As many of the BIEL testimonial videos say, it changed my life.
"the marketplace is inundated with competing electronic pain relief products."
The market has a lot of Tens type units but very few portable PEMF units that weigh less than an ounce. As discussed many times Tens technology merely blocks the pain signal from getting to your brain. It does nothing to help your body heal. PEMF = reduced pain and accelerated healing.
On a separate subject I did a follow up on my Carpal Tunnel test yesterday. Before my 4 hour bicycle ride I used double Actipatches, top and bottom of the right fore arm/wrist, for 22 hours over 3 days. The same set up during the ride. Tingling and numbness would normally occur in the 50 minute to 1 hour range. Yesterday however I went 3 hours until there was any tingling. It was minor and never progresses into numbness.
Over 4 million Americans suffer from Carpal Tunnel Syndrome and 500k have surgery each year. This is another large market for the ActiPatch.
I hope that you are correct wyatt. Unfortunately the FDA does not operate under the rules of a normal business. They only have to answer to Congress and the President. If you or I miss a deadline at work we would have some explaining to do, to the client and our boss. But the FDA is the "Only Game In Town" when it comes to government approval for a medical device. As Ms. Burns in the Medical Device Division wrote when she replied to my inquiry regarding the FDA not meeting its own 180 day goal in early September,there is an "ongoing balancing of priorities". I read that as we have more pressing issues to deal with.
I believe it was simpsonly who speculated that 180 days to the FDA may exclude weekends and holidays. This would place us into late October for the goal. However Ms. Burns, who could have used this as an easy excuse, mentioned nothing to contradict my statement that her department had missed its 180 day goal.
The only leverage that we have over the FDA is through our Congressman and Senators. Write them and let them know that 46 Americans die each day from pain medication abuse. PEMF offers a safe non addictive alternative to opiate drugs for relief from pain. The USA is decades behind the rest of the world in utilizing this technology because of poor leadership (allegiance to big pharma) in the FDA.
3 new promotional videos for the UK market. ActiPatch solves chronic pain issues that pills can not, with no side effects.
Thanks for kicking us up to .0015 Tazzer. A nice way to end the week.
A lot of buying @ .0015 late in the day. We are usually dead after 3pm. Could be a good sign.
Seven, Thanks for the 10/12 message. Has anyone ever received a response from the Medical Device Ombudsman? I sent a letter 4 weeks ago and never got any acknowledgement of receipt or response.
Carpal Tunnel Syndrome , another PEMF market. I have been experiencing numbness in my right hand on long bicycle rides due to carpal tunnel syndrome. Today I placed an ActiPatch on top and another on the bottom of my lower arm / wrist, held on by an elastic arm sleeve. On a 4 hour ride there was a substantial reduction in numbness, about 50%. I am going to do the same treatment during the coming week and see what next weekends ride feels like.
Over 4 million Americans suffer from carpal tunnel syndrome.
I agree seven, light a fire under the FDA. I have done the same. This delay is ludicrous. There are calls for the director of the FDA, Margaret Hamburg, to resign due to the epidemic of pain medication abuse and the FDA sits on a safe alternative to addictive opiate drugs, PEMF.
The US is decades behind the rest of the world in utilizing PEMF. This is the reason that we consume 80 percent of the worlds pain medication, resulting in 46 deaths per day. It does not take a genius to connect the dots on this one. It is time for Hamburg to clear PEMF or resign and take a job with big pharma.
http://abcnews.go.com/blogs/politics/2014/09/at-white-house-prescription-drug-protesters-call-for-new-fda-chief/
http://www.mintpressnews.com/fda-accused-of-fuelling-record-painkiller-addiction-epidemic/197120/
http://www.thefix.com/content/bipartisan-congressional-letter-protests-fda%E2%80%99s-approval-highly-addictive-prescription
http://www.usatoday.com/story/news/nation/2014/09/24/addiction-painkillers-fda-margaret-hamburg/16150421/
I am normally a calm person but the FDA is truly trying my patience.
Thank you for the 9/27 advice.
Here is the breakdown for 9/30. While the volume was low this was a solid move up with only 782k shares out of a 11.3 million share day trading below Monday's close of .0014 .
.0013...............782k
.0014..............4516k
.0015..............2882k
.0016..............1110k
.0017..............1085k
.0019..............1000k
A small teaser of what is to come when the FDA reclassifies PEMF.
Bioelectronics has been producing products for over a decade. I have personally used them for the last seven years and they have had a major positive impact on my quality of life. I am sure that many of the members of this board could relate a similar experience. Bioelectronics is not a scam but a company in the right place at the right time as America is finally waking up from a nightmare of opioid addiction and open to non addictive pain relief.
In your post #42937 you state " There was almost 20 Million in an after close T-trade at an average of 14. So it went some 13s and 14s making 13.5 average or listed at 14(same daily range). Without that it was 20 Million in buys and 11.4 in sells. And that was due to VFIN (company)diluter moving down to 14 taking out a chunk and making the ask much lower, as it was setting a new low. So the T-trade was in the same range of dilution where the whole days trading was, 13-14. There was only some few 15s because it opened there."
Here is the definition of a "T" trade from IHUB:
'T' If reporting a single protected transaction.
A protected transaction occurs when a large order is going through the market. The buyer (or seller) may wish to keep the order anonymous from the rest of the market as the size of the order could greatly alter the price of the stock. With a protected transaction, the dealer will put the trade through in small quantities rather than knock the whole order out in one hit. The entire transaction is reported once the deal is completed. The LSE is notified at the start and at the end of the transaction. However, the market as a whole isn't told until the end, thus the order is protected.
The trade was recorded at .0014 and was protected because "The buyer (or seller) may wish to keep the order anonymous from the rest of the market as the size of the order could greatly alter the price of the stock." Contrary to what you portray the "T" trade was done to hold the stock down.
You further state "Yet, the FDA wait, only to be declined, Andy makes his family money off raising and dumping shares so out outrageously high, that why stop if someone still buys this garbage?". This reclassification for PEMF is not Andy's request it is an internal FDA proposal. The FDA thinks the FDA's regulations regarding PEMF are excessive and wants to correct them.
Dear Stockdarockk,
In post #42964 you wrote "Almost everything today dumped at 13. Even 11 Million one trade. They dont even care anyone how it looks." This trade was listed as an "Average" by IHUB. So contrary to your portrayal , 11 million did not trade at .0013 but between .0013 and .0014 with the Average being closer to .0013.
On Friday over 5.4 million shares traded at .0014, when the 11 million share Average trade is taken for what it is, an average, saying "Almost everything today dumped at 13" is a distortion of the facts to promote an agenda.
You also state " Then a painted close at 14. Its sad when you have to paint 14s for your close." After the 11 million share Average trade was recorded over 500k shares traded at .0014 . An attempt at a paint was made as a 7k share trade posted at .0013 . The final trade of the day was for 75k shares at .0014 .
Looks a little fishy to me. 40.1 million on the buy side vs 11.1 million on the sell side and we drop 6%??? MM's fingerprints are all over this one.
6 million shares dumped between 12:22 and 12:40 to break the .0014 support.
100% correct seven.
My estimate is for the reclassification event only. The other positives in the pipeline, 510k submittal, partnership/licensing announcement, 510k approval, OTC approval, will all have their own impact on the share price. BIEL will be more like a locomotive than a rocket, picking up speed as each of these positive events kicks in.
If on the other hand the FDA, feeling the heat from pain med abuse (see TAZZER's post), should grant a special Low Voltage class of PEMF with easy OTC access in their reclassification BIEL
would blast off.
Thanks for the link TAZZER. Nice to see the FDA taking some heat for a flawed policy that contributes to 46 US deaths each day by pain medication overdose.
IMHO there is a lot cash sitting on the side lines ready to jump in when the FDA, in its infinite wisdom, gets around to finalizing the reclassification. Minimum .008, maximum .012 + depending on the specifics of the final reclassification.
Thanks for the link wyatt. I made it to page 46 before my eyes glazed over.
The 9/16 Daily Show had a great segment on the Mafia like control that Big Pharma has over Doctors and the FDA. It specifically deals with pain meds. I highly recommend viewing it.
http://thedailyshow.cc.com/videos/qrq3eo/the-pharmaceutical-drug-epidemic
Thanks for all the quality information that you provide to the board Simpsonly.
One more positive attributable to the delay. My BIEL odometer rolled past 10,000,000 shares this week. It will now be much easier to count the money as BIEL ascends to penny land and beyond.
I'm not much of a hard liquor drinker but when Covington starts brewing a Yam Craft Beer I will be all over it.
One of the few benefits to the FDA delay is that BIEL has more time to line up their ducks and be ready to hit the ground running with their 510Ks.
What are we on now day 200 of a 180 day process. The only way the FDA can look professional at this point is if they needed the extra time to reduce the regulations for the low powered PEMFs.
The ActiPatch is definitely in the PEMF Sweet Spot. Proven PEMF benefits, accelerated healing and reduced pain, without spending hundreds or thousands of dollars for an elaborate PEMF system. $29.95 for 720 hours of therapy.
As the word about PEMF technology spreads the Bioelectronics line of products will be very attractive to consumers.
The Neurometrics unit is a Tens that is designed specifically for Diabetic Peripheral Neuropathy. Customers pay a monthly $30 for electrodes and $500 if they don't return the unit in good condition.
1) Tens systems block the pain signal, doing nothing to heal the cause of the pain. Unlike the Actipatch which helps damaged tissue heal.
2) The Neurometrics unit is designed for a specific indication, Diabetic Peripheral Neuropathy. It has a limited market. The Actipatch works on any type of tissue damage, head to toe.
3) Neurometrics has customers sign a contract, $30 a month and $500 charged to your CC if the electronics are not returned in good condition. Actipatch is $30 for 720 hours of therapy. No commitments and no $500 electronics to worry about.
Glad to hear that you have volunteered as a BIEL Guinea Pig seven!!
Keep us posted on your progress. When I use the ActiPatch on my lower back there is a definite increase in blood flow to the family jewels.
I agree about the squeak getting attention in the business world. Inquiring in a respectful manor as to why the FDA has not met Their Own timeline on PEMF reclassification (not BIEL reclassification) is not out of line or going to delay the process.
If everyone who is interested in a timely conclusion to the reclassification of PEMF devices, the FDA's own proposal now past its own 180 day completion goal, were to politely write to Ms. Burns it could have an impact. The FDA is a public agency. If enough of the "public" rattle their cage, politely, it has to have an impact.
mailto:Melissa.Burns@fda.hhs.gov
Reply to an inquiry that I made to Melissa Burns @ FDA:
Unfortunately, I cannot give any specific estimates on when a final order will issue. The comment period is closed and we are considering the comments received on the proposed order. The amount of time for development and review of FDA’s responses to the comments and the final order itself is reliant on the types of comments received and ongoing balancing of priorities. We are aware that there is significant interest from manufacturers, patients, and other stakeholders in us bringing this classification effort to a timely conclusion.
Regards,
Melissa
Fear not StockinUp, no canine orifices were compromised in this study. One of the pictures in the link shows the PEMF in action. We will use PG protocol and call it external, lower tummy application.
I think the dogs in this study were all truly "Lucky Dogs". After the Treatment they could run around all day with their friends and not have to stop for a bathroom break every 30 minutes, unless of course trees and fire hydrants were near. And considering the semen samples that were analyzed everyone had a happy ending.
http://www.ncbi.nlm.nih.gov/pubmed/24913937
PEMF and Prostates. A canine study released last month found that 3 weeks of PEMF treatment on 20 dogs with Benign prostatic hyperplasia (BPH) reduced prostate size by an average of 57%. No negative side effects were reported.
50% of US males have some level of BPH by age 50 and the percentage grows larger with age.
Come on FDA, lets make this technology available.
http://www.ncbi.nlm.nih.gov/pubmed/24913937
They are probably approved for one indication for use via prescription just as Bioelectronics is FDA approved for Blepharoplasty, eyelid surgery, by prescription. In selling through the internet the company or a distributor is doing what BIEL did until they received a letter from the FDA demanding a stop to this activity. The MD Cure device is not approved for OTC sales.
Thanks for the Cuvamove info yankee, further proof that pemf is a viable technology. At $1500 the Curamove requires a significant investment as compared to the Actipatch $29 cost. Curamove is promoted as a portable device but strapping on a 6"x4" box that weighs 250 grams is a world away from the Actipatch at 8 grams and invisible under clothing.
For me the extra time that the FDA is spending on our reclassification is a positive as I have been able to add to my position.
Any theories on why we had a 87% short ratio on 8/11?
date................short vol.....total vol.
20140815|BIEL|1786811|0|18934625|O..................................
20140814|BIEL|2983889|0|5852889|O...................................
20140813|BIEL|2715691|0|4636091|O...................................
20140812|BIEL|3089000|0|9107000|O...................................20140811|BIEL|12220456|0|14049232|O
Pet Patch Review: I decided to join seven-up and purchase a Pet Patch for my mule. The new Patch has several improvements over my 4 year old ActiPatch.
1) The wire loop has gone to a heavier gauge, about 14 vs about 18-20 for the old Patch. I wonder if it has had an effect on potency.
2) The foam pad on the back of the old Patch is gone. This is probably a good thing as the foam was most likely a bacteria sponge.
3) No more sliding the plastic wafer between the battery and circuit board to kill power. There is a slick push button on/off switch in the center of the back side, also a pop on safety cover for the switch to prevent accidental activation/deactivation.
4) The circuit board is now completely encased in plastic. This gives the unit a more sleek, professional look and reduces the thickness from 3/8" on the old to 1/4" on the new. Those who replaced batteries on the old Patch may be out of luck with this new design.
5) The pilot light that tells the user the Patch is active has changed color from red to green and is noticeably brighter.
6) Glad to see that Heal Fast charged the actual $5.05 cost for its Priority Mail delivery service.
These changes have made the Patch a much more professional, user friendly device. My mule will be very happy.
Thanks for shedding some light on the process Simpsonly. If there is a Letter of Intent before the FDA decision do you see the interested party working with BIEL towards an FDA OTC approval?